JPMorgan Chase & Co. Has $614,000 Stake in Enhabit, Inc. (NYSE:EHAB)

JPMorgan Chase & Co. trimmed its holdings in Enhabit, Inc. (NYSE:EHAB) by 74.3% in the 4th quarter, HoldingsChannel.com reports. The fund owned 78,574 shares of the company’s stock after selling 226,671 shares during the quarter. JPMorgan Chase & Co.’s holdings in Enhabit were worth $614,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Paradice Investment Management LLC lifted its holdings in shares of Enhabit by 12.8% during the fourth quarter. Paradice Investment Management LLC now owns 1,780,113 shares of the company’s stock worth $13,903,000 after buying an additional 201,997 shares during the last quarter. Fox Run Management L.L.C. raised its stake in Enhabit by 290.2% during the 4th quarter. Fox Run Management L.L.C. now owns 42,237 shares of the company’s stock valued at $330,000 after purchasing an additional 31,412 shares during the last quarter. Magnetar Financial LLC bought a new stake in Enhabit in the 4th quarter valued at $171,000. AlphaQuest LLC increased its holdings in shares of Enhabit by 106.3% during the 4th quarter. AlphaQuest LLC now owns 33,310 shares of the company’s stock worth $260,000 after purchasing an additional 17,166 shares during the period. Finally, Versor Investments LP raised its position in shares of Enhabit by 135.0% during the fourth quarter. Versor Investments LP now owns 28,900 shares of the company’s stock valued at $226,000 after buying an additional 16,600 shares during the last quarter.

Enhabit Trading Up 0.2 %

Shares of Enhabit stock opened at $7.95 on Wednesday. Enhabit, Inc. has a 52-week low of $6.85 and a 52-week high of $10.70. The firm has a market capitalization of $401.06 million, a PE ratio of -3.42 and a beta of 1.60. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.46 and a quick ratio of 1.46. The company’s fifty day moving average price is $8.29 and its two-hundred day moving average price is $8.01.

Wall Street Analyst Weigh In

Separately, Jefferies Financial Group reissued a “buy” rating on shares of Enhabit in a research report on Thursday, March 6th.

About Enhabit

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.